[Disclosure] Hana Micron (067310) – (Correction) Decision on Capital Increase with and without Consideration / 2024-06-18 Semiconductors
[Disclosure] Hanwha Systems (272210) – Signs KRW 142.1B Contract with DAPA for TICN System PBL Project Disclosures
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18 Disclosures
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Crohn’s Disease) / 2024-06-18 Disclosures
[Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract (Correction) / 2024-06-18 Disclosures
[Disclosure] Hanwha Systems (272210) – (Correction) Correction Filing Regarding KRW 34.7B 1st Tranche Convertible Note Acquisition of U.S. OVERAIR, INC. Upon Maturity Disclosures
[Disclosure] Hanwha Systems (272210) – (Correction) Correction Filing Regarding KRW 64.3B Convertible Note Acquisition of U.S. OVERAIR, INC. Upon Maturity Disclosures
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-06-17 Disclosures
![[Disclosure] Hana Micron (067310) – (Correction) Decision on Capital Increase with and without Consideration / 2024-06-18](https://kstockbriefing.com/wp-content/uploads/2026/06/포맷변환-하나마이크론.jpg)
![[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
![[Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract (Correction) / 2024-06-18](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성바이오로직스.jpg)
![[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract (Correction) / 2024-06-18](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)